Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
종목 코드 ZLAB
회사 이름Zai Lab Ltd
상장일Sep 28, 2020
CEODr. Du (Samantha) Ying, Ph.D.
직원 수1869
유형Depository Receipt
회계 연도 종료Sep 28
주소Building B, 899 Halei Road, Pudong
도시SHANGHAI
증권 거래소NASDAQ Global Market Consolidated
국가China
우편 번호201203
전화862161632588
웹사이트https://www.zailaboratory.com/
종목 코드 ZLAB
상장일Sep 28, 2020
CEODr. Du (Samantha) Ying, Ph.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음